| Financial Year |
March 31 2023 |
| Monetary Funds |
754,324,603.57 |
| Held-for-trading Financial Assets |
170,461,562.80 |
| Notes Receivable |
-- |
| Accounts Receivable |
79,835,713.31 |
| Advances to Suppliers |
12,231,253.73 |
| Other Receivables |
2,933,272.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
79,655,117.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,206,425.79 |
| Total Current Assets |
1,104,647,948.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
499,240,516.08 |
| Under-construction Projects |
40,688,212.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
125,456,143.88 |
| R&D expenses |
-- |
| Goodwill |
22,178,945.14 |
| Long-Term Deferred and Prepaid Expenses |
12,060,288.41 |
| Deferred Income Tax Assets |
10,807,992.56 |
| Other Non-Current Assets |
459,350,719.44 |
| Sub-Total of Non-Current Assets |
1,576,698,287.63 |
| Total Assets |
2,681,346,236.19 |
| Short-Term Loans |
35,006,125.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
127,542,931.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,411,116.92 |
| Taxes Payable |
15,927,717.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
184,974,277.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,089,827.48 |
| Other Current Liabilities |
214,821.22 |
| Sub-Total of Current Liabilities |
413,595,238.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
85,514,617.35 |
| Other Non-Current Liabilities |
4,015,126.36 |
| Sub-Total of Non-Current Liabilities |
155,792,383.42 |
| Total Liabilities |
569,387,622.11 |
| Paid-In Capital(Or Share Stock) |
250,113,750.00 |
| Capital Surplus |
801,078,879.94 |
| Surplus Reserve |
116,879,638.19 |
| LESS:Treasury Stock |
32,784,262.50 |
| Undistributed Profits |
973,770,586.02 |
| Minority Stockholder's Interest |
2,900,022.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,109,058,591.65 |
| Owner's Equity（Stockholder's Equity） |
2,111,958,614.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,681,346,236.19 |
